RxDoctor Payments Data

Keith Harbour, DO

Family Medicine · Haltom City, TXNPI 1518985316

Payments from drug & device makers

$855in general payments, 2019–2025

Across 48 payments — averaging $17.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$146
  • Lilly USA, LLC$143
  • Novo Nordisk$87
  • Boehringer Ingelheim$86
  • GSK$81
  • Exact Sciences$73
  • plus $238 from 9 others

What the payments were for

  • Food & beverage$855100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$855 in reported general payments places this provider in the 55th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas

Medicare billing

Part B allowed, 2024
$24,226
Medicare patients
65
Services billed
340

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OxycontinOxycodone Hcl12$42,106
JanuviaSitagliptin Phosphate18$18,703
OzempicSemaglutide11$16,858
FarxigaDapagliflozin Propanediol15$12,219
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen138$7,865
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog18$6,488
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr13$6,070
BelsomraSuvorexant12$4,996
Lantus SolostarInsulin Glargine,hum.Rec.Anlog19$2,248
Albuterol Sulfate HfaAlbuterol Sulfate70$1,778
Gabapentin94$1,667
SynthroidLevothyroxine Sodium11$1,141
Trazodone Hcl104$992
Fentanyl11$931
Atorvastatin Calcium125$911

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
MerckJanuvia, Belsomra$11$23,69930 claims
Novo NordiskOzempic$87$16,85811 claims
AstraZenecaFarxiga$71$12,21915 claims
GSKAnoro Ellipta$81$6,07013 claims
AbbVieSynthroid$146$1,14111 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 8,760 family medicine providers in Texas.

Other family medicine in Haltom City

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →